Leader Migraine Relief

Description

Acetaminophen, Aspirin (NSAID), and Caffeine are combined in a formulation designed for pain relief. This product is presented in the form of gelatin-coated tablets, with a total of 80 GELTABS per container. The combination of these active ingredients provides an effective aid for the relief of pain.

Uses and Indications

This drug is indicated for the treatment of migraine.

There are no teratogenic effects associated with this medication. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

Adults are instructed to take 2 geltabs with a full glass of water. It is essential not to exceed the maximum dosage of 2 geltabs within a 24-hour period unless otherwise directed by a healthcare professional. For individuals under 18 years of age, dosing should be determined by a physician.

Contraindications

Use is contraindicated in patients with a history of allergic reactions to acetaminophen, aspirin, or any other pain reliever or fever reducer. Additionally, this product should not be used concurrently with any other medication containing acetaminophen, whether prescription or nonprescription. If there is uncertainty regarding the presence of acetaminophen in other medications, consultation with a healthcare professional is advised.

Warnings and Precautions

Children and teenagers who are experiencing or recovering from chickenpox or flu-like symptoms should avoid using this product due to the risk of Reye’s syndrome. If any changes in behavior accompanied by nausea and vomiting occur while using this product, it is imperative to consult a healthcare professional, as these symptoms may indicate the onset of this rare but serious condition.

Allergy Alerts Acetaminophen, a component of this product, has been associated with severe skin reactions. Symptoms may include skin reddening, blisters, and rash. Should any skin reaction occur, the use of the product must be discontinued immediately, and medical assistance should be sought.

Aspirin, another ingredient, may provoke a severe allergic reaction characterized by hives, facial swelling, asthma (wheezing), or shock. Immediate medical attention is warranted if any of these symptoms arise.

Liver Warning This product contains acetaminophen, which poses a risk of severe liver damage if the following conditions are met: exceeding the maximum daily dosage of 2 geltabs within a 24-hour period, concurrent use with other medications containing acetaminophen, or consumption of three or more alcoholic drinks daily while using this product.

Stomach Bleeding Warning As this product contains a nonsteroidal anti-inflammatory drug (NSAID), it may increase the risk of severe stomach bleeding. The likelihood of this adverse effect is heightened in individuals who are 60 years of age or older, have a history of stomach ulcers or bleeding disorders, are taking anticoagulants or steroid medications, are using other NSAIDs (including aspirin, ibuprofen, or naproxen), consume three or more alcoholic drinks daily, or exceed the recommended duration or dosage of the product.

Medication Overuse Headache Warning Prolonged use of this product, specifically for 10 or more days per month, may exacerbate headache symptoms.

Caffeine Warning The recommended dosage of this product contains approximately the same amount of caffeine as a standard cup of coffee. It is advisable to limit the intake of other caffeine-containing medications, foods, or beverages during treatment, as excessive caffeine consumption may lead to severe nervousness, irritability, insomnia, and, in some cases, rapid heartbeat.

Emergency Medical Help In the event of an overdose, immediate medical assistance should be sought, or contact a Poison Control Center at 1-800-222-1222.

Discontinuation and Consultation Healthcare professionals should advise patients to stop using the product and seek medical advice if any of the following occur: an allergic reaction, signs of stomach bleeding (such as feeling faint, vomiting blood, having bloody or black stools, or experiencing persistent stomach pain), if migraine symptoms are not alleviated or worsen after the first dose, if new or unexpected symptoms arise, or if there is ringing in the ears or loss of hearing.

Side Effects

Patients using this product may experience a range of adverse reactions, some of which can be serious.

Serious adverse reactions include the risk of Reye’s syndrome, particularly in children and teenagers who have or are recovering from chickenpox or flu-like symptoms. If patients exhibit changes in behavior accompanied by nausea and vomiting, they should consult a healthcare professional immediately, as these may be early signs of this rare but serious illness.

Severe allergic reactions may occur, particularly in patients sensitive to acetaminophen or aspirin. Symptoms of severe skin reactions associated with acetaminophen may include skin reddening, blisters, and rash. In the case of an allergic reaction to aspirin, symptoms may include hives, facial swelling, asthma (wheezing), and shock. Patients experiencing any of these symptoms should discontinue use and seek medical attention promptly.

Liver damage is a significant concern, especially if patients exceed the maximum recommended dosage of two geltabs in 24 hours, use other products containing acetaminophen, or consume three or more alcoholic drinks daily while using this product. Additionally, the product contains an NSAID, which may increase the risk of severe stomach bleeding, particularly in patients aged 60 or older, those with a history of stomach ulcers or bleeding problems, or those taking anticoagulants or other NSAIDs. Patients should be vigilant for signs of stomach bleeding, such as feeling faint, vomiting blood, having bloody or black stools, or experiencing persistent stomach pain.

Medication overuse headaches may occur if the product is used for 10 or more days per month. Furthermore, the caffeine content in the recommended dose is comparable to that of a cup of coffee, and patients are advised to limit the intake of other caffeine-containing products to avoid severe nervousness, irritability, sleeplessness, and, occasionally, rapid heartbeat.

Patients should stop using the product and consult a doctor if they experience any allergic reactions, signs of stomach bleeding, worsening migraines, new or unexpected symptoms, or symptoms such as ringing in the ears or loss of hearing.

Before using this product, patients should seek medical advice if they have never had migraines diagnosed, experience headaches that differ from their usual migraines, have the worst headache of their life, or have accompanying symptoms such as fever and stiff neck. Additional caution is advised for patients with a history of liver disease, stomach problems, high blood pressure, heart disease, liver cirrhosis, or kidney disease, as well as those taking diuretics or other medications for serious conditions.

Drug Interactions

Concurrent use of this product with other medications containing acetaminophen is contraindicated due to the potential for hepatotoxicity. Additionally, the use of this product alongside other prescription or nonprescription nonsteroidal anti-inflammatory drugs (NSAIDs), such as aspirin, ibuprofen, or naproxen, is also not recommended, as it may increase the risk of adverse effects.

Patients should consult a healthcare professional prior to using this product if they are concurrently taking anticoagulants or steroid medications, as these combinations may necessitate careful monitoring or dosage adjustments.

Furthermore, it is advisable to limit the intake of caffeine-containing medications, foods, or beverages while using this product to avoid potential overstimulation or adverse effects associated with excessive caffeine consumption.

No specific laboratory test interactions have been identified in the available data.

Packaging & NDC

Below are the non-prescription pack sizes of Leader Migraine Relief (acetaminophen, aspirin, caffeine). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product due to the risk of Reye’s syndrome. If any changes in behavior accompanied by nausea and vomiting occur while using this product, it is important to consult a doctor, as these symptoms may indicate the onset of Reye’s syndrome, a rare but serious condition.

For pediatric patients under 18 years of age, it is advised to consult a doctor before use.

Geriatric Use

Elderly patients, specifically those aged 60 years and older, should consult a healthcare provider prior to using this medication. This precaution is essential to ensure the safe and effective use of the treatment in this population, as age-related physiological changes may influence drug metabolism and response. Careful consideration and monitoring are advised when prescribing to geriatric patients to mitigate potential risks and optimize therapeutic outcomes.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional before using this medication. The use of aspirin during pregnancy, particularly at 20 weeks gestation or later, is associated with potential risks. Specifically, it may lead to adverse effects on fetal development or complications during delivery. Therefore, it is crucial that pregnant patients only use aspirin under the guidance of a qualified healthcare provider if deemed necessary.

Lactation

Lactating mothers are advised to consult a health professional before using this medication. It is particularly important to avoid the use of aspirin at 20 weeks of pregnancy or later unless specifically directed by a physician, as it may pose risks to the unborn child or lead to complications during delivery. There is no specific data available regarding the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, caution is recommended when considering the use of this medication during lactation.

Renal Impairment

Patients with renal impairment should consult a healthcare professional prior to use, particularly if they have conditions such as high blood pressure, heart disease, liver cirrhosis, or kidney disease. It is essential to assess renal function and consider potential dosing adjustments or monitoring requirements based on the severity of renal impairment.

Hepatic Impairment

Patients with hepatic impairment should exercise caution when using this product, as it contains acetaminophen, which is associated with the risk of severe liver damage. It is critical that patients do not exceed the maximum daily dosage of 2 geltabs within a 24-hour period. Additionally, patients must avoid concurrent use with other medications containing acetaminophen and limit alcohol consumption to fewer than 3 alcoholic drinks per day while using this product.

Before initiating treatment, patients with liver disease or any significant hepatic impairment should consult a healthcare professional. This recommendation also extends to individuals with high blood pressure, heart disease, liver cirrhosis, or kidney disease, as these conditions may further complicate the safe use of this product. Regular monitoring of liver function may be warranted in patients with compromised liver health to mitigate the risk of adverse effects.

Overdosage

In the event of an overdose, it is imperative to seek immediate medical assistance or contact a Poison Control Center at 1-800-222-1222. Prompt intervention is crucial for both adults and children, even in the absence of noticeable signs or symptoms.

Healthcare professionals should be aware that the lack of immediate symptoms does not preclude the potential for serious health consequences. Therefore, it is essential to monitor the patient closely and provide appropriate medical care as needed.

Nonclinical Toxicology

It is especially important not to use aspirin at 20 weeks or later in pregnancy unless definitely directed to do so by a doctor, as it may cause problems in the unborn child or complications during delivery. No specific non-teratogenic effects or additional nonclinical toxicology details are available in the provided data. Furthermore, there are no specific findings related to animal pharmacology and toxicology.

Postmarketing Experience

Postmarketing experience has identified several adverse events reported voluntarily or through surveillance programs. Instances of allergic reactions have been documented, necessitating immediate medical attention. Additionally, signs indicative of stomach bleeding have been reported, including feelings of faintness, vomiting of blood, presence of bloody or black stools, and persistent stomach pain.

Reports also indicate that some patients may experience unresolved or worsening migraines following the initial dose. Furthermore, new or unexpected symptoms have been noted, along with occurrences of tinnitus or hearing loss.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center at 1-800-222-1222 in the event of an overdose. It is crucial to emphasize that quick medical attention is necessary for both adults and children, even if no signs or symptoms are initially apparent.

Patients should be instructed to discontinue use and consult a doctor if they experience any signs of an allergic reaction, and to seek medical help without delay. Additionally, they should stop use and contact a healthcare professional if they notice any symptoms indicative of stomach bleeding, such as feeling faint, vomiting blood, having bloody or black stools, experiencing persistent stomach pain, or if their migraine is not alleviated or worsens after the first dose. New or unexpected symptoms, as well as ringing in the ears or loss of hearing, should also prompt a consultation with a doctor.

Healthcare providers should encourage patients to discuss their medical history and any current symptoms before using the medication. Patients should be advised to consult a doctor if they have never had migraines diagnosed by a health professional, if they experience a headache that differs from their usual migraines, or if they have the worst headache of their life. They should also seek medical advice if they have a fever accompanied by a stiff neck, headaches that begin after a head injury, exertion, coughing, or bending, or if they experienced their first headache after the age of 50.

Patients with daily headaches, migraines severe enough to require bed rest, liver disease, or a history of stomach problems such as heartburn should also be encouraged to consult a doctor prior to use. Furthermore, those with high blood pressure, heart disease, liver cirrhosis, or kidney disease, as well as individuals taking diuretics or who have asthma, should seek medical advice before using the medication.

It is important for patients to inform their healthcare provider if they have experienced serious side effects from pain relievers or fever reducers, or if they have vomiting associated with migraine headaches. Patients should also be advised to consult a doctor or pharmacist if they are taking prescription medications for diabetes, gout, or arthritis, or if they are under a doctor’s care for any serious condition. Lastly, patients should be reminded to discuss any other medications or products they are taking that contain aspirin, acetaminophen, or other pain relievers/fever reducers with their healthcare provider or pharmacist.

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers, which should be referenced for accurate identification. It is essential to store the product at a controlled temperature range of 20° to 25°C (68° to 77°F) to maintain its efficacy.

After each use, the cap must be closed tightly to prevent contamination and ensure the integrity of the product. Users are advised to read all product information thoroughly before use and to retain the packaging for future reference, as it contains important information regarding the product.

Additional Clinical Information

The medication is administered orally. Clinicians should advise patients who are pregnant or breastfeeding to consult a health professional prior to use. It is particularly crucial to avoid the use of aspirin at 20 weeks of gestation or later unless specifically directed by a physician, as it may pose risks to the unborn child or lead to complications during delivery.

Drug Information (PDF)

This file contains official product information for Leader Migraine Relief, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)